Holding(s) in Company

RNS Number : 4832E

Immupharma PLC

09 February 2018

 

                                                                                                                              9 February 2018

ImmuPharma PLC

("ImmuPharma" or the "Company")

Holding in Company

ImmuPharma PLC (LSE: IMM), the specialist drug discovery and development company, announces that on 8 February 2018 it received notification that Alto Invest no longer holds a notifiable interest in the Company.  

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

For further information, please contact:

ImmuPharma plc (www.immupharma.com) Tim McCarthy, Chairman Lisa Baderoon, Head of Investor Relations [e-mail]	[phone] [phone]
Northland Capital Partners Limited David Hignell, Jamie Sportswood (Corporate Finance) Rob Rees (Corporate Broking)	[phone]

 

END

 

 

HOLXKLFBVLFZBBK